Dyskeratosis congenita: genes and variants
Explore variant evidence for Dyskeratosis congenita across 3 analyzed proteins (TERT, POT1, NPM1). Linked ClinVar records include 24 pathogenic or likely pathogenic variants, 1,202 variants of uncertain significance and 179 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Dyskeratosis congenita
TERT: Telomerase reverse transcriptase
It extends telomeric DNA using an internal RNA template and helps counter progressive chromosome-end shortening in stem and proliferative cells. Loss-of-function variants cause telomere-biology disorders, while promoter activation and increased activity support unlimited proliferation in many cancers.
23 ClinVar pathogenic / likely pathogenic and 1,378 uncertain variants in TERT have source records linked to Dyskeratosis congenita. Association strength is not clinical gene validity.
POT1: Protection of telomeres protein 1
It binds the single-stranded ends of telomeres and helps control telomerase access while preventing chromosome ends from being mistaken for DNA breaks. Germline loss-of-function variants predispose to several cancers, including melanoma, glioma, and chronic lymphocytic leukemia, and can produce unusually long telomeres.
1 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in POT1 have source records linked to Dyskeratosis congenita. Association strength is not clinical gene validity.
NPM1: Nucleophosmin
It coordinates ribosome biogenesis, nucleolar stress responses, centrosome regulation, and nucleocytoplasmic transport. Recurrent frameshift variants that mislocalize the protein to cytoplasm define one of the most common molecular subtypes of acute myeloid leukemia.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NPM1 have source records linked to Dyskeratosis congenita. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): TNXB.
Where Dyskeratosis congenita variants cluster
- TERT Reverse transcriptase (positions 605–935): 14 of 23 ClinVar pathogenic / likely pathogenic variants, 2.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Dyskeratosis congenita
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TERT A716V | 716 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT A716T | 716 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT R865H | 865 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT R631Q | 631 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT R631W | 631 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT A880T | 880 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT T567M | 567 | Pathogenic / likely pathogenic (★★) | |
| TERT R671W | 671 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT V867M | 867 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| TERT A1009V | 1009 | CTE | Pathogenic / likely pathogenic (★★) |
| TERT G1063S | 1063 | CTE | Pathogenic / likely pathogenic (★★) |
| TERT P704S | 704 | Reverse transcriptase | Pathogenic / likely pathogenic (★★) |
| POT1 C503G | 503 | Pathogenic / likely pathogenic (★) | |
| TERT E484D | 484 | QFP motif | Pathogenic / likely pathogenic (★) |
| TERT F883C | 883 | Reverse transcriptase | Pathogenic / likely pathogenic (★) |
| TERT D685N | 685 | Reverse transcriptase | Pathogenic / likely pathogenic (★) |
| TERT G110V | 110 | GQ motif | Pathogenic / likely pathogenic (★) |
| TERT A130V | 130 | GQ motif | Pathogenic / likely pathogenic (★) |
| TERT I686M | 686 | Reverse transcriptase | Pathogenic / likely pathogenic (★) |
| TERT A1040T | 1040 | CTE | Pathogenic / likely pathogenic (★) |
| TERT K570N | 570 | Pathogenic / likely pathogenic | |
| TERT K902N | 902 | Reverse transcriptase | Pathogenic / likely pathogenic |
| TERT S947P | 947 | CTE | Pathogenic / likely pathogenic |
| TERT P908L | 908 | Reverse transcriptase | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Dyskeratosis congenita
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| TERT R865C | 865 | Reverse transcriptase | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R865H at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.929 |
Which prediction tools work for Dyskeratosis congenita
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- EVE: 100 out of 100
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 88 out of 100
- CADD: 87 out of 100
- MutPred: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 84 out of 100
- SIFT: 81 out of 100
- ESM1b (LLR): 80 out of 100
- Pangolin: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related also has ClinVar records linked to TERT variants; they fall mostly in different places as the Dyskeratosis congenita variants (13 pathogenic / likely pathogenic).
- Tumor predisposition syndrome also has ClinVar records linked to POT1 variants; they fall mostly in different places as the Dyskeratosis congenita variants (8 pathogenic / likely pathogenic).
Diseases related to Dyskeratosis congenita
- Acute myeloid leukemia, also linked to NPM1 and TERT
- Familial melanoma, also linked to POT1 and TERT
- Urinary bladder cancer, also linked to TERT
- Non-small cell lung carcinoma, also linked to NPM1
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, also linked to TERT
- Idiopathic pulmonary fibrosis, also linked to TERT
- Melanoma, cutaneous malignant, also linked to TERT
- Lung adenocarcinoma, also linked to TERT
- Tumor predisposition syndrome, also linked to POT1
- Hepatocellular carcinoma, also linked to TERT
- Prostate cancer, also linked to TERT
- Lung carcinoma, also linked to TERT
Frequently asked questions
Which genes have records linked to Dyskeratosis congenita?
This view contains 3 analyzed proteins: TERT, POT1, NPM1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 24 pathogenic or likely pathogenic variants, 1,202 variants of uncertain significance and 179 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,459 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center